Friday 31^st January 2020

13:45      Welcome and introduction (D. Betticher, Fribourg)

Combined radio (chemo) immunotherapy in the curative setting (M. Guckenberger)

13:50      Rational for Combined Radioimmunotherapy (T. Finazzi, Amsterdam)

14:20      For early and locally advanced NSCLC (O. Riesterer, Aarau)

14:50      For head and neck squamous cancer (P. Balermpas, Zürich)

15:20      Discussion

15:30      Coffee break

Chemo-Immunotherapy combinations (without radiation) in the metastatic setting (S. Peters)

16:15      Overview in NSCLC (IO/IO; IO/chemo) (A. Curioni Zürich)

16:45      Overview in GI malignancies (IO/chemo, incl. gastric and oeophageal) (M. Montemurro, Lausanne)

17:15      Overview in Head and Neck carcinoma (K. Harrington, London)

17:45      Case presentation by attendees/discussion

18:30      Adjourn

Saturday 1^st February 2020

Combined Radioimmunotherapy in the metastatic setting (D. Zwahlen)

08:00      Concept of Oligometastatic disease (M. Guckenberger, Zürich)

08:30      SBRT as immune-enhancing agent (F. Herrera, Lausanne)

09:00      Local therapy and IO for brain metastases (B. Baumert, Chur)

09:30      Case presentation by attendees/discussion

10:00      Coffee break

Other Immunotherapy combinations in the metastatic setting (B. Baumert)

10:30      Anti-angiogenic and IO across tumors (S. Peters, Lausanne)

11:00      Glioma (vaccines, IO and CAR T cells) (D. Migliorini, Genève)

11:30      Local ablative therapies and IO (A. Digklia, Lausanne)

12:00      Wrap up (M. Guckenberger, Zürich)

12:15      End